Skip to content

Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04068844
Enrollment
93
Registered
2019-08-28
Start date
2019-08-01
Completion date
2026-04-01
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Diastolic

Keywords

Exercise, Hemodynamics,, Heart failure

Brief summary

The global objective of this study is to determine the mechanisms of exercise intolerance and dyspnea on exertion (DOE) in patients with HFpEF and based on this pathophysiology, test whether specific exercise training programs (whole body vs single leg) will result in improved exercise tolerance.

Detailed description

This will be a randomized, non-blinded prospective intervention testing the effects of two types of exercise training, whole body and isolated single leg, on HFpEF patients with either central or peripheral limitations to exercise training. Subjects will undergo baseline maximal exercise testing and invasive right heart catheterization to define exercise tolerance and pulmonary and cardiac pressures during exercise. Based on the results of baseline testing, subjects will be divided into either centrally limited, defined as excessive rise in pulmonary capillary wedge pressure more than 25 mmHg that decreases after administration of sub-lingual nitroglycerin resulting in improved exercise tolerance, or peripherally limited, defined as no improvement in exercise tolerance despite reduction in pulmonary capillary wedge pressure after sublingual nitroglycerin. After baseline testing, subjects will be randomized to either whole body cycle exercise supplemented with sublingual nitroglycerin to improve training responsiveness or isolated single leg exercise training for 4 months. After 4 months, subjects will repeat maximal exercise testing and invasive right heart catheterization to assess responses to 4 months of exercise training.

Interventions

BEHAVIORALExercise training

Exercise training, either whole body or isolated single leg

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER
The University of Texas at Arlington
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

HFpEF patients with either central or peripheral limitations to exercise will be randomly assigned to either whole body or isolated single leg exercise.

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* signs and symptoms of heart failure * an ejection fraction \> 0.50 * objective evidence of diastolic dysfunction

Exclusion criteria

* age \< 60 years * BMI \> 50 kg/m2 * PDE5 inhibitor use * Severe valvular disease * Severe COPD * CKD 4 or higher * Contra-indication to MRI.

Design outcomes

Primary

MeasureTime frameDescription
Aerobic fitness4 monthsChange in peak VO2 after exercise training

Secondary

MeasureTime frameDescription
Cardiopulmonary hemodynamics4 monthsChange in exercise pulmonary capillary wedge pressure
Sympathetic activity4 monthsChange in muscle sympathetic activity
Leg blood flow4 monthsChange in leg blood flow assessed by Doppler velocities in femoral artery
Cardiac fibrosis4 monthsChange in T1 mapping times by cardiac MRI

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026